EKSO

#4430
Ekso Bionics Holdings, Inc. Common Stock
11.6100 USD
+2.11%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
11.0400
11.6150
Intervallo Annuale
7.8900
13.5000
Variazione giornaliera
+2.11%
Variazione Mensile
+15.98%
Variazione di 6 mesi
-7.27%
Variazione Annuale
-7.27%
Chiusura Precedente
11.3700
Apertura
11.4400
Minimo
11.0400
High
11.6150
Volume
18
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Ekso Bionics Holdings Inc

Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community.

Notizie